is berberine a glp-1 receptor agonist as multi-target therapeutic agent for obesity: from pharmacological mechanisms to clinical evidence | European Journal of Medical Research Berberine vs GLP-1: Key Differences

The findings of a new study suggest that an apparent association between GLP-1 medications and thyroid cancer may be due to more intensive patient screening, and not a side effect of the drugs themselves.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and obesity, have shown promise in modulating reward-related brain pathways, suggesting potential benefits in the management of AUD

GLP-1 therapy is a proven tool for weight management and metabolic health, but side effects can interfere with consistency

Do GLP-1 drugs cause blood clots

Codeage GLP-Advantage+ capsules supplement utilizes an advanced liposomal delivery and time-release matrix

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are two gut hormones, defined incretins, responsible for the amplification of insulin secretion after oral glucose intake